Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1989
06/20/1989US4841047 Antiallergens
06/20/1989US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance
06/20/1989CA1256113A1 Process for preparing 4h-1,2,4-triazole derivatives
06/15/1989WO1989005352A1 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF
06/15/1989WO1989005346A1 Stimulation of stem cell growth by the bryostatins
06/15/1989WO1989005304A1 Macrocyclic compounds
06/15/1989WO1989005295A1 Acyl derivatives of hydroxypyrimidines
06/15/1989WO1989005151A1 High integrity liposomes and method of preration and use
06/15/1989WO1989005149A1 Methyl cellulose pharmaceutical composition
06/15/1989WO1989005145A1 Method of inhibiting the activity of leukocyte derived cytokines
06/15/1989WO1989004875A3 Characterization and detection of sequences associated with autoimmune diseases
06/14/1989EP0320267A2 Glycoprotein growth modulation materials
06/14/1989EP0320118A2 Peptides with collagenase inhibiting activity
06/14/1989EP0319947A2 Bis-S-alkylbenzene derivatives
06/14/1989CN1033379A Acyl derivatives of hydroxy pyrimidines
06/13/1989US4839389 Treatment of diseases caused by human or animal immunodeficiency; effective against infectious diseases; escherichia
06/13/1989US4839387 Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
06/13/1989CA1255599A1 Pharmaceutical compositions containing a 1-substituted methoxy-4-trimethyl-1,2,3,6 benzene derivative
06/07/1989EP0319463A2 Use of 4H-benzo[4,5]cyclohepta[1,2-b]thiophene derivatives to effect monokine inhibition
06/07/1989EP0319333A2 Method for the prevention of graft versus host disease
06/07/1989EP0319170A2 Acyl derivatives of hydroxy pyrimidines
06/07/1989EP0319012A2 Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension
06/06/1989USRE32944 Aromatic carboxylic amide derivatives
06/06/1989US4837235 Indole and indazole keto sulphones as leukotriene antagonists
06/06/1989US4837202 Administering somatotropin and prolactin
06/06/1989CA1255300A1 Method of inducing immunosuppression
06/06/1989CA1255230A1 Pharmaceutical composition containing podophyllotoxin or a derivative thereof
06/01/1989WO1989004875A2 Characterization and detection of sequences associated with autoimmune diseases
06/01/1989WO1989004834A1 Immunoglobulin e competitor
06/01/1989WO1989004829A1 Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
06/01/1989WO1989004825A1 New derivatives of cysteine, processes for their preparation and their use
06/01/1989WO1989004675A1 Selective removal of immune complexes
05/1989
05/31/1989EP0318296A2 Interleukin-1 receptors
05/31/1989EP0318214A1 Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof
05/31/1989EP0318093A2 Diarylquinoline diacids and their use as medicaments
05/31/1989EP0318090A2 Tert-butyl phenyl compounds as anti-inflammatory agents
05/31/1989EP0318085A2 Heterazole dialkanoic acids
05/31/1989EP0318084A2 Benzoheterazoles
05/31/1989EP0318083A2 Pyridyl dialkanoic acids and their use as medicaments
05/31/1989EP0317933A2 Treatment of fibromyalgia
05/31/1989EP0317749A2 Substituted benzimidazoles and benzothiadiazoles
05/30/1989US4835189 Phenolic thioalkylamides as inhibitors of 5-lipoxygenase
05/30/1989US4835178 Methylendioxyphenathrene and stilben derivatives, process for the preparation thereof, pharmaceutical compositions using these, and therapeutic applications
05/30/1989US4835175 Indole derivatives pharmaceutical preparations based thereon, and β-receptor stimulation therewith
05/30/1989US4834974 Immunologically active whey fraction and recovery process
05/24/1989EP0317540A1 Cysteine derivatives, processes for their preparation and their use
05/24/1989EP0317165A1 DI-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
05/24/1989EP0316820A1 Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
05/24/1989EP0316639A2 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
05/24/1989EP0316633A1 Medicine containing azelastine for application in the nose and/or at the eye
05/24/1989EP0316456A1 Ester-substituted thienotriazolodiazepine compounds and their medicinal use
05/24/1989CN1033074A Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
05/23/1989US4833131 Anticarcinogenic agents
05/23/1989CA1254437A1 Growth stimulant for animals
05/18/1989WO1989004306A1 Fused pyridazine compounds and their medicinal uses
05/18/1989WO1989004305A1 Quinoline derivatives as antagonists of leukotriene d4
05/18/1989WO1989004304A1 Quinoline derivatives as antagonists of leukotriene d4
05/18/1989WO1989004303A1 Quinoline derivatives as antagonists of leukotriene d4
05/18/1989WO1989004175A1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
05/18/1989WO1989004168A1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
05/18/1989WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/17/1989EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent
05/17/1989EP0316174A1 Aqueous preparation of 9-methyl-3-(1H-tetrazol-5-yl)-4H-Pyrido[1,2-a]pyrimidin-4-one potassium salt
05/17/1989EP0316022A2 Tricyclic compounds
05/17/1989CN1032935A Fluorinated arachidonic acid derivatives
05/16/1989US4831020 Ingredient effective for activating immunity obtained from Chlorella minutissima
05/16/1989CA1254222A1 N-(phenyl) or n-(phenycyclopropyl)-2,5-dihydro-2-oxo- 4¬(substituted phenyl)amino|-3-furancarboxamide derivatives
05/16/1989CA1254204A1 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones
05/16/1989CA1254139A1 Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer
05/10/1989EP0315519A2 Aminopimelic acid derivatives, process for their preparation and their use as medicines
05/10/1989EP0315399A2 Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same
05/10/1989EP0315219A2 Pharmaceutical compositions
05/10/1989EP0315218A2 Pharmaceutical compositions
05/10/1989EP0315166A2 Fluorinated arachidonic acid derivatives
05/10/1989EP0315153A2 Vaccine adjuvant
05/10/1989EP0315112A2 Novel amide compounds
05/10/1989EP0315110A2 Use of the tumor necrosis factor as adjuvant of the immune response
05/10/1989EP0315071A2 Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics
05/10/1989CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same
05/10/1989CN1032741A Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell
05/10/1989CN1032739A Pharmaceutical composition for piperidinoalkanol derivatives
05/09/1989US4829080 Skin disorders, psoriasis, acne
05/09/1989US4829077 Benzopyran[4,3-d]-thiazole-derivatives with anti-allergic, anti-anaphylactic and anti-arithritic activity and compositions containing them
05/09/1989US4829061 1-(4-Hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use
05/09/1989CA1253871A1 Diphenylmethylimine derivatives
05/05/1989WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/05/1989WO1989003837A1 Acylated uridine and cytidine and uses thereof
05/05/1989WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent
05/05/1989WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application
05/03/1989EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
05/03/1989EP0314528A1 Article for the controlled release and delivery of substances to animal tissues
05/03/1989EP0314464A1 Thiophene derivatives
05/03/1989EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/03/1989EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them
05/03/1989EP0314008A2 N-substituted aliphatic heterocyclic compounds able to facilitate the passage of active substances through physiological barriers
05/03/1989EP0313997A2 Medicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparing those heterocyclic compounds
05/03/1989EP0313697A1 Leukotriene antagonists
05/03/1989EP0313641A1 Activation antigen
05/02/1989US4827032 Intermediates for anticoagulants
05/02/1989US4826990 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents